NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
University Hospital of Lausanne · University of Lausanne · +28 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
841
total citations
- FWCI
- 16.72
- Percentile
- 100%
- References
- 33
Citations per year
Authors
35Topics & keywords
Topics
Keywords
- Medicine
- Chemotherapy
- Adverse effect
- Internal medicine
- Hazard ratio
- Rash
- Clinical endpoint
- Surgery
No related works found for this paper.